Obesity in the elderly: Should we be using new diagnostic criteria? Patrick Ritz Editorial 10 May 2009 Pages: 168 - 169
Low serum carotenoids are associated with a decline in walking speed in older women N. AlipanahR. VaradhanRichard D. Semba Low Serum Carotenoids 10 May 2009 Pages: 170 - 175
Low relative skeletal muscle mass indicative of sarcopenia is associated with elevations in serum uric acid levels: Findings from NHANES III K. M. BeaversD. P. BeaversR. L. Wilson JNHA: Nutrition 10 May 2009 Pages: 177 - 182
Effect of fluid and food intake on the body composition evaluation of elderly persons K. H. C. VilaçaE. FerriolliJulio C. Moriguti JNHA: Nutrition 10 May 2009 Pages: 183 - 186
Synapse formation is enhanced by oral administration of uridine and DHA, the circulating precursors of brain phosphatides Richard J. WurtmanM. CansevI. H. Ulus JNHA: Clinical Neurosciences 10 May 2009 Pages: 189 - 197
Fish consumption and cognitive function among older people in the UK: Baseline data from the OPAL study A. D. DangourE. AllenR. Uauy Fish Consumption and Cognitive Function Among Older People in the UK 10 May 2009 Pages: 198 - 202
CTAD international research conference: Clinical trials in Alzheimer’s disease S. GauthierJ. TouchonZ. Katchaturian Editorial 10 May 2009 Pages: 204 - 204
Evolution of Aβ42 and Aβ40 levels and Aβ42/Aβ40 ratio in plasma during progression of Alzheimer’s disease: A multicenter assessment K. BlennowG. De MeyerKnd-Study Group JNHA: Clinical Trials and Aging 10 May 2009 Pages: 205 - 208
Neuroimaging outcomes in clinical trials in Alzheimer’s disease Giovanni B. FrisoniA. Delacourte JNHA: Clinical Trials and Aging 10 May 2009 Pages: 209 - 212
GAB2 gene does not modify the risk of Alzheimer’s disease in Spanish APOE 4 carriers Reposo Ramírez-LorcaM. BoadaA. Ruiz GAB2 Gene Does Not Modify the Risk of Alzheimer’s Disease in Spanish APOE 4 Carriers 10 May 2009 Pages: 214 - 219
The influence of matrix type, diurnal rhythm and sample collection and processing on the measurement of plasma β-amyloid isoforms using the INNO-BIA plasma Aβ forms multiplex assay D. R. LachnoH. VandersticheleR. A. Dean The Inno-Bia Plasma Aβ Forms Multiplex Assay 10 May 2009 Pages: 220 - 225
Critical evaluation of self-rated quality of life in mild cognitive impairment and Alzheimer’s disease — Further evidence for the impact of anosognosia and global cognitive impairment Martin BerwigH. LeichtH. J. Gertz Critical Evaluation of Self-Rated Quality of Life in Mild Cognitive Impairment and AD 10 May 2009 Pages: 226 - 230
Short review: Acetylcholinesterase-inhibitors in Alzheimer’s disease have opposing effects on blood pressure and cerebral perfusion Jurgen A. H. R. ClaassenA. H. E. A. Van BeekM. G. M. Olde-Rikkert JNHA: Clinical Trials and Aging 10 May 2009 Pages: 231 - 233
New insights into clinical trial for colostrinin™ in Alzheimer’s disease P. SzaniszloP. GermanI. Boldogh JNHA: Clinical Trials and Aging 10 May 2009 Pages: 235 - 241
Cost-effectiveness of post-diagnosis treatment in dementia coordinated by multidisciplinary memory clinics in comparison to treatment coordinated by general practitioners: An example of a pragmatic trial Els J. MeeuwsenR. J. F. MelisM. G. M. Olde Rikkert AD-Euro Study 10 May 2009 Pages: 242 - 248
Analytic methods for factors, dimensions and endpoints in clinical trials for Alzheimer’s disease R. E. Tractenberg JNHA: Clinical Trials and Aging 10 May 2009 Pages: 249 - 255
Bridging from clinical endpoints to estimates of treatment value for external decision makers C. W. ZhuC. LeibmanY. Stern Bridging from Clinical Endpoints to Estimates of Treatment Value for External Decision Makers 10 May 2009 Pages: 256 - 259
Methodological issues in the non pharmacological treatment of BPSD in nursing home — the TNM study — E. LeoneA. DeudonP. H. Robert Methodological Issues in the Non Pharmacological Treatment of BPSD in Nursing Home 10 May 2009 Pages: 260 - 263
Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing A. SchneebergerM. MandlerW. Schmidt Second Generation AD Vaccines 10 May 2009 Pages: 264 - 267
Methodological improvements in quantifying cognitive change in clinical trials: An example with single-dose administration of donepezil R. H. PietrzakP. MaruffPeter J. Snyder Methodological Improvements in Quantifying Cognitive Change in Clinical Trials 10 May 2009 Pages: 268 - 273
Delirium due to a drug-drug interaction of lithium and an NSAID R. A. FaaijG. ZiereT. J. M. Van Der Cammen JNHA: Geriatric Science 10 May 2009 Pages: 275 - 276
Dizziness in an older community dwelling population: A multifactorial syndrome K. G. GassmannR. Rupprecht Dizziness in an Older Community Dwelling Population 10 May 2009 Pages: 278 - 282
The accuracy of monthly weight assessments in nursing homes: Implications for the identification of weight loss Sandra F. SimmonsE. N. PetersonC. You Accuracy of Monthly Weight Assessments 10 May 2009 Pages: 284 - 288